Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0928 FDA Latinos
BioCentury  & Getty Images

Politics, Policy & Law

FDA panelists propose steps towards increasing Latino enrollment in cancer trials

Sep 29, 2020 | 1:01 AM GMT

During a public meeting hosted by FDA last week, a panel of academics and regulators proposed steps industry can take to increase participation by Latino patients in cancer trials. 

“It’s important from a population perspective that we understand if

Read the full 623 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE